Interestingly, we found that BCO patients had higher levels of serum adiponectin than COPD patients without bronchiectasis (p < 0.001) (Table 2), suggesting a different regulation of adiponectin expression in exacerbated patients. The gene discussed is ADIPOQ; the disease is bronchiectasis.